Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
2012
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
2014
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
2011 Standout
Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD
2004
Coagulation disorders and hemostasis in liver disease
2006
Sepsis biomarkers: a review
2010 Standout
Hepatic stellate cells as key target in liver fibrosis
2017
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
2019
Acute kidney injury
2012 Standout
Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone
2005
ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase
2011
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
2007 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Mechanisms of hepatic stellate cell activation
2017 Standout
MELDvsChild-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis
2005
Burden of liver diseases in the world
2018 Standout
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Paeoniflorin diminishes ConA-induced IL-8 production in primary human hepatic sinusoidal endothelial cells in the involvement of ERK1/2 and Akt phosphorylation
2015
Renal Failure in Cirrhosis
2009
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
2013
Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?
2003
Hepatocellular carcinoma
2021 Standout
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: Impact of exogenous neuropeptide Y
2012
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
2009
MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study
2002
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
2011
Expanding consensus in portal hypertension
2015 Standout
Vascular disorders of the liver # †
2008 Standout
Neutropenic enterocolitis
2006
Liver fibrosis and repair: immune regulation of wound healing in a solid organ
2014
Portal hypertension and variceal bleeding—Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
2008
Nociceptin and urotensin-II concentrations in critically ill patients with sepsis
2008
Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension
2013
Management of Hepatocellular Carcinoma *
2005 Standout
Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD
2003
Acute kidney injury
2019 Standout
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child–Turcotte–Pugh score
2005
Elevated Soluble Tumor Necrosis Factor Receptor 75 Concentrations Identify Patients With Liver Cirrhosis at Risk of Death
2008
Sepsis and septic shock
2018 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Photodynamic therapy for unresectable cholangiocarcinoma: A comparative effectiveness systematic review and meta-analyses
2012
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
2009 StandoutNobel
Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002
2006
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Air embolism complicating gastrointestinal endoscopy: A systematic review
2013
Management of Varices and Variceal Hemorrhage in Cirrhosis
2010
Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go?
2004
A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage
2007
Hepatorenal Disorders
2015
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Global burden of liver disease: 2023 update
2023 Standout
Peroral endoscopic myotomy (POEM) for esophageal achalasia
2010 Standout
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension
2006
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients
2013
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Vascular mediators in the injured liver
2003
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
2019 Standout
Renal failure and cirrhosis: A systematic review of mortality and prognosis
2011
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
2012
Liver involvement in hereditary hemorrhagic telangiectasia (HHT)
2007
‘Repair’ Treg Cells in Tissue Injury
2017
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed # †
2009
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Nucleotide‐binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis†
2009
The model for end-stage liver disease (MELD)
2007
Is urotensin‐II the new endothelin?
2002
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Cellular senescence: from physiology to pathology
2014 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Adverse events associated with ERCP
2016 Standout
Elevated interleukin‐8 in bile of patients with primary sclerosing cholangitis
2016
Endoscopic Band Ligation Versus Pharmacological Therapy for Variceal Bleeding in Cirrhosis: A Meta-Analysis
2011
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis
2007
Uncommon and rarely reported adverse events of endoscopic retrograde cholangiopancreatography
2013
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
2012
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study
2013
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Achalasia: botox, dilatation or laparoscopic surgery in 2006
2006
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Rare and underappreciated complications of endoscopic retrograde cholangiopancreatography
2014
Works of Michael Schepke being referenced
Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension
2002
Comparison of Portal Vein Velocity and The Hepatic Venous Pressure Gradient in Assessing The Acute Portal Hemodynamic Response To Propranolol in Patients With Cirrhosis
2000
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
2001
Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis
1999
Hemodynamic Effects of Propranolol and Nitrates in Cirrhotics with Transjugular Intrahepatic Portosystemic Stent-Shunt
2002
Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteins
2007
Magnetic resonance (MR) imaging and MR angiography for evaluation and follow-up of hepatic artery banding in patients with hepatic involvement of hereditary hemorrhagic telangiectasia
2006
Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study
2006
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
2015
Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis
2002
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
2007
Transjugular Intrahepatic Portosystemic Shunting is not Superior to Endoscopic Variceal Band Ligation for Prevention of Variceal Rebleeding in Cirrhotic Patients: a Randomized, Controlled Trial
2002
Total ascitic fluid leukocyte count for reliable exclusion of spontaneous bacterial peritonitis in patients with ascites
2006
Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C
2013
Combination of Bilateral Metal Stenting and Trans-Stent Photodynamic Therapy for Palliative Treatment of Hilar Cholangiocarcinoma
2010
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis†
2004
Long-Term Results and Prognostic Factors in the Treatment of Achalasia with Botulinum Toxin
2002
Neutropenic enterocolitis in adults: systematic analysis of evidence quality
2005
Comparison of Meld, Child-Pugh, and Emory Model for The Prediction of Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunting
2003
Prognostic Impact of Renal Impairment and Sodium Imbalance in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunting for the Prevention of Variceal Rebleeding
2003
Biliary Metal Stents and Air Embolism: A Note of Caution
2006
Increased urotensin II plasma levels in patients with cirrhosis
2001